Alterity Therapeutics Appoints Abby Macnish Niven as Company Secretary

ATHE Stock  USD 1.06  0.01  0.95%   
About 54% of Alterity Therapeutics' investor base is interested to short. The analysis of overall sentiment of trading Alterity Therapeutics stock suggests that many investors are impartial at this time. The current market sentiment, together with Alterity Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Alterity Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
MELBOURNE, Australia and SAN FRANCISCO, Nov. 19, 2024 -- Alterity Therapeutics , has a

Read at gurufocus.com
Gurufocus Stories at Macroaxis
  

Alterity Therapeutics Fundamental Analysis

We analyze Alterity Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alterity Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alterity Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Book Value Per Share

Book Value Per Share Comparative Analysis

Alterity Therapeutics is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Alterity Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alterity Therapeutics stock to make a market-neutral strategy. Peer analysis of Alterity Therapeutics could also be used in its relative valuation, which is a method of valuing Alterity Therapeutics by comparing valuation metrics with similar companies.

Peers

Alterity Therapeutics Related Equities

TARAProtara Therapeutics   13.08   
0%
74.0%
RNAZTranscode Therapeutics   11.76   
0%
67.0%
ANTXAN2 Therapeutics   3.73   
0%
21.0%
VCNXVaccinex   3.65   
0%
20.0%
SRZNSurrozen   3.19   
0%
18.0%
QNRXQuoin Pharmaceuticals   1.69   
0%
9.0%
MNPRMonopar Therapeutics   0.26   
0%
1.0%
ARTLArtelo Biosciences   0.90   
5.0%
0%
ADILAdial Pharmaceuticals   0.99   
5.0%
0%
PMVPPmv Pharmaceuticals   1.24   
7.0%
0%
ELYMEliem Therapeutics   1.32   
7.0%
0%
NBYNovaBay Pharmaceuticals   1.61   
9.0%
0%
ATXIAvenue Therapeutics   1.92   
10.0%
0%
RVPHReviva Pharmaceuticals   2.61   
14.0%
0%
ANEBAnebulo Pharmaceuticals   4.11   
23.0%
0%
HCWBHCW Biologics   8.20   
46.0%
0%
ADTXAditxt   17.50   
100.0%
0%

Complementary Tools for Alterity Stock analysis

When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Technical Analysis
Check basic technical indicators and analysis based on most latest market data